GlassScriptPhysician profile
Amy E Hitchens
NPI 1356730311
$7,768.29
in general payments reported to CMS, 2019-2025
32 companies · $2,868 in 2025
The $2,868 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $854 · 2022: $941 · 2023: $897 · 2024: $2,209 · 2025: $2,868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,552 · Education: $272 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,551.69 |
| Education | $271.60 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,898.15 | 2021-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $1,149.38 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Genzyme Corporation | $914.84 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $591.58 | 2021-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $549.75 | 2022-2025 | |
| Harmony Biosciences LLC | $387.75 | 2022-2025 | Wakix |
| Axsome Therapeutics, INC. | $347.69 | 2023-2025 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $296.40 | 2023-2025 | Glassia |
| United Therapeutics Corporation | $283.73 | 2021-2025 | Tyvaso, Tyvaso |
| Verona Pharma, INC. | $216.28 | 2025 | Ohtuvayre |
| Sanofi-Aventis U.S. LLC | $176.98 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $146.44 | 2023-2025 | Purified Cortrophin Gel |
| Mylan Specialty L.P. | $105.69 | 2021-2023 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.95 | 2021-2022 | |
| Pulmonx Corporation | $72.03 | 2024-2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $65.05 | 2025 | Yupelri |
| Inspire Medical Systems, INC. | $51.08 | 2025 | Inspire |
| Lilly USA, LLC | $36.28 | 2025 | Zepbound, Mounjaro |
| Teva Pharmaceuticals USA, INC. | $34.42 | 2022 | |
| Grifols USA, LLC | $33.73 | 2021-2025 | Prolastin-C Liquid |
| Amgen INC. | $33.05 | 2022-2023 | Tezspire |
| Insmed, INC. | $32.88 | 2025 | Arikayce |
| Philips North America LLC | $32.32 | 2021-2022 | |
| Tactile Systems Technology INC | $30.02 | 2025 | Flexitouch Plus, Nimbl |
| Baxter Healthcare | $27.22 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Exact Sciences Corporation | $27.21 | 2025 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.15 | 2025 | Caplyta |
| Actelion Pharmaceuticals US, INC. | $21.57 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $21.56 | 2025 | Lumryz |
| Optinose US, INC. | $21.27 | 2024 | |
| Zoll Respicardia, INC. | $19.14 | 2025 | Remede System |
| Boston Scientific Corporation | $17.70 | 2025 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Hitchens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.